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loid-b (Ab) peptide play central roles in the pathology and
etiology of Alzheimer’s disease. Amyloid-induced impair-
ments in neurogenesis have been investigated in several
transgenic mouse models but the mechanism of action
remains to be conclusively demonstrated. The changes in
neurogenesis during this transition of increasing Ab levels
and plaque formation were investigated in the present
study. We found that the proliferation of newborn cell in
the dentate gyrus was enhanced prior to elevations in solu-
ble Ab production as well as amyloid deposition in 5-week-
old TgCRND8 mice, which are well-established Alzheimer’s
disease models, compared to non-transgenic (Non-Tg)
mice. The number of BrdU-positive cells remained higher
in TgCRND8 vs Non-Tg mice for a period of 8 weeks. The
numbers of BrdU/NeuN-positive cells were not signiﬁcantly
diﬀerent in TgCRND8 compared to Non-Tg mice. A signiﬁ-
cant decrease in BrdU/GFAP but not in BrdU/S100b was
found in Tg vs Non-Tg at 6-weeks of age. In addition, a
unique observation was made using isolated neuroprogeni-
tor cells from TgCRND8 mice which were found to be less
viable in culture and produced substantial amounts of
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52of neural progenitors in vivo may be modulated by high lev-
els of APP expression and the resulting Ab generated
directly by the progenitor cells. These ﬁndings indicate that
cell proliferation is increased prior to Ab deposition and that
cell viability is decreased in TgCRND8 mice over time.
 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
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disease, transgenic mice.INTRODUCTION
Neurogenesis occurs throughout life with active adult
neurogenesis occurring in the subventricular zone (SVZ)
in the lateral ventricle and the subgranular zone (SGZ)
of the dentate gyrus in the hippocampus (Gage, 2000).
Neurogenesis in SVZ is related to odor discrimination
and memory (Gheusi et al., 2000; Rochefort et al.,
2002; Magavi et al., 2005). In the SGZ new neurons are
involved in learning and memory (Deng et al., 2009).
During neurogenesis, various key factors contribute to
the process of diﬀerentiation from neural stem cells to
mature neurons (Ming and Song, 2011). For example,
glial ﬁbrillary acidic protein (GFAP) is expressed in the
ﬁrst stage of neurogenesis. Meanwhile, the neuronal
nuclear antigen (NeuN) is induced in the later phases.
Alzheimer’s disease (AD) is a prevalent
neurodegenerative disorder, the principle clinical feature
of which is progressive dementia beginning in late adult
life. This is accompanied by a characteristic set of
neuropathological features including senile plaques,
neuroﬁbrillary tangles, and neurodegeneration of
speciﬁc areas of the brain. The hippocampal formation
is one of the most aﬀected areas in the AD brain
(Selkoe, 2000). Senile plaques are composed of
extracellular accumulation of amyloid-b (Ab) peptides.
Neuroﬁbrillary tangles are intracellular aggregates of
hyper-phosphorylated tau proteins, which function to
stabilize neuronal microtubules under normal conditions.
At present three causative genes are known to be
associated with autosomal dominant, fully penetrant
familial AD, namely, amyloid precursor protein (APP),
presenilin-1 (PS1) and presenilin-2 (PS2) (Goate et al.,
1991; Sherrington et al., 1995; Rogaev et al., 1995).
Mutations in these proteins lead to alterations in the
processing of Ab peptides from APP, resulting in more
toxic forms of Ab peptides in plaques. Several animal
models of AD pathology related to the three genes have
been established. To date, many studies using thed.
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the correlation between AD pathology and neurogenesis
(Lazarov and Marr, 2010; Mu and Gage, 2011). There
are a few studies that report understanding of
neurogenesis on AD (Jin et al., 2004; Ziabreva et al.,
2006), but the status of neurogenesis individuals with
AD has not been deﬁned yet.
In this study, we investigated the eﬀect of AD
pathology on neurogenesis using well-established
TgCRND8 mouse model of AD (Chishti et al., 2001). In
TgCRND8 mice, prior to the onset of increased soluble
Ab peptide production and amyloid plaque
accumulation, the number of newborn cells in the SGZ
was greater than that of non-transgenic (Non-Tg)
littermates. However, once the brain levels of Ab began
to increase, the number of newborn cells fell, and their
diﬀerentiation to neural progenitor cells (NPCs) was
impaired in TgCRND8 compared to that of Non-Tg
littermates. These results indicate that at later stages
where Ab and APP are increased there is a decrease in
the number of progenitor cells and their subsequent
diﬀerentiation in TgCRND8 mice is impaired. The
investigation of neurospheres isolated from the amyloid
mice displayed a signiﬁcant decrease in cell viability that
may be related, in part, to Ab toxicity.
EXPERIMENTAL PROCEDURES
Transgenic mouse model
TgCRND8 mice expressing both human Swedish mutant
and Indiana mutant of APP, driven by the hamster prion
(PrP) promoter were previously characterized (Chishti
et al., 2001). Animals at diﬀerent stages of development
were investigated to determine the eﬀects of amyloid
pathology on neurogenesis. TgCRND8 mice and Non-
Tg littermates at 5 weeks of age were injected with
5-bromo-2-deoxyuridine (BrdU) intraperitoneally twice a
day for 5 days. Animals were sampled at intervals of 1,
2, 4, 6 or 8 weeks from the start date of injection. All
animal studies followed the University of Toronto Animal
Care Policies and Guidelines and were approved by the
University Animal Care Committee of University of
Toronto.
Antibodies
The following antibodies were used for this study. Rat
anti-BrdU monoclonal (1:2000; Accurate Chemical &
Scientiﬁc), mouse anti-NeuN monoclonal (1:2000;
Chemicon) for mature neuron, mouse anti-S100b
monoclonal (1:2000; Sigma–Aldrich) for mature
astrocytes, and mouse anti-GFAP monoclonal (1:2000;
Cell Signaling) for neural precursor and mature
astrocytes. As secondary antibodies, donkey anti-rat
conjugated with horse radish peroxidase (HRP) and
donkey anti-mouse conjugated with HRP (1:200;
Jackson Immunoresearch Laboratory) were used.
BrdU injection
BrdU was dissolved in phosphate-buﬀered saline (PBS)
at the concentration of 3 mg/ml. BrdU solution wasadministered to mice intraperitoneally at the
concentration of 50 mg/kg twice a day for ﬁve
consecutive days.Immunohistochemistry
Immunohistochemistry was performed as described
previously (Kee et al., 2007). Brieﬂy, mice were
perfused with 0.1 M PBS and with 4% buﬀered
paraformaldehyde. Brains were removed from the skull
and immersed in 4% paraformaldehyde at 4 C for 12 h.
Fixed tissues were placed in 30% sucrose at 4 C until
they settled at the bottom. Samples were frozen and
sectioned at 50 lm with a cryostat. Sectioned samples
were placed into 24-well plates ﬁlled with 0.1 M PBS
(pH 7.4), washed with 0.1 M PBS three times, immersed
into 1 N HCl for 30 min at 37 C in order to denature
DNA, and then placed in a blocking solution composed
of mouse immunoglobulin G (1:200, Jackson
Immunoresearch Laboratory) in 0.1 M PBS for 1 h at
room temperature. Sections were then immersed into
1% hydrogen peroxide solution for 30 min at room
temperature for quenching endogenous peroxidase, and
incubated with primary antibodies at 4 C for 15 h.
Thereafter, sections were incubated with secondary
antibodies for 1 h at room temperature. For signal
enhancement, TSA-biotin and TSA-ﬂuorescein system
(Perkin Elmer) were used according to the
manufacturer’s protocols. Following each step described
above, 0.1 M PBS (pH 7.4) wash was conducted three
times before proceeding to the next step. Nuclei were
counter-stained with Hoechst 33258 (Sigma). After
staining, sections were mounted on slides with antifade
ﬂuorescence mounting medium (Dako). Slides were
observed with ﬂuorescence microscopy or confocal
microscopy, and BrdU-positive cells in the dentate gyrus
were counted. A total of 48 sections from the dentate
gyrus region were prepared from each animal with ﬁve
animals in each condition were examined for the
quantiﬁcation. Sections were sorted sequentially to four
groups (12 sections/group) and immunostained with
BrdU only or BrdU plus the desired markers NeuN,
S100b or GFAP. The total number of positive cells was
counted from each of the entire sections.Neurosphere isolation
Neural stem cells were isolated from TgCRND8 mice and
Non-Tg littermates at 4 months of age. The protocol of
isolation was as previously described (Visanji et al.,
2011). Brieﬂy, whole brains of TgCRND8 mice and Non-
Tg littermate mice (n= 10) were cut into pieces
(2 mm3) and incubated at 37 C in 10 ml/g tissue of
Dulbecco’s modiﬁed Eagle medium (DMEM) containing
papain (2.5 units/ml), protease type 1 (1 unit/ml), and
DNase I (250 units/ml). The tissue was triturated every
5 min until a smooth consistency was achieved
(30 min). Following digestion, the cell suspension was
mixed with an equal volume of DMEM/F-12/N2
containing 10% fetal bovine serum (FBS). The
suspension was then passed through a sterilized 70-lm
nylon mesh ﬁlter and centrifuged (1000g for 3 min).
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10% FBS and mixed with an equal volume of Percoll (9:1
v/v Percoll/PBS) and centrifuged (20,000g for 30 min at
18 C). NPCs were harvested from the low buoyancy
fraction just above the red blood cell layer. Cells were
washed in cold PBS containing an antibiotic–antimycotic
solution (containing penicillin, streptomycin, and
amphotericin B) before plating in DMEM/F-12/N2
containing and antibiotic–antimycotic solution, ﬁbroblast
growth factor-basic (bFGF) (20 ng/ml), epidermal growth
factor (EGF) (20 ng/ml), and heparin (5 lg/ml).
Proliferating NPC began to grow in clusters 2–3 weeks
post-isolation. During this period, half the media was
changed weekly, and bFGF (20 ng/ml), EGF (20 ng/ml),
and heparin (5 lg/ml) were added every 3–4 days.Ab quantiﬁcation and c-secretase inhibition
Ab40 and Ab42 levels were measured by enzyme-linked
immunoabsorbent assay (ELISA) using conditioned
medium collected from cultured neurospheres isolated
from Non-Tg and TgCRND8 mice. The ELISA
(Biosource International) was performed as previously
described (Pardossi-Piquard et al., 2009). For Ab
quantiﬁcation, neurosphere media was conditioned for
4 days with samples taken from paired cultures (Non-Tg
and TgCRND8) between passages 3 and 7. To assess
the eﬀects of c-secretase inhibition, cells were treated
overnight with 100 nM Compound E (Santa Cruz) and
dimethyl sulfoxide (DMSO) was used as a negative
control as previously described (Beher et al., 2001).Propidium iodide and nuclear staining
Neurospheres were cultured in fresh DMEM/F12 growth
medium supplemented with N2 (1X); Heparin 5 lg/ml;
EGF 20 ng/ml; bFGF 20 ng/mL were plated in 12-well
dishes (approximately 10,000 cells/well) (NUNC) and
allowed to grow for 4 days undisturbed. At this point, the
medium was carefully removed to avoid disturbing the
cells and the cells were stained with propidium iodide
(100 lg/ml) and Hoechst 33258 (50 lg/ml) for 15 min.
The staining solution was removed and the cells were
rinsed once with PBS pH 7.4. The cells were ﬁxed in cold
4% buﬀered paraformaldehyde for 30 min. After ﬁxation,
the cells were rinsed three times with PBS pH 7.4 and
stored in PBS in the dark until used. Hoechst and
propidium iodide (PI)-positive cells were counted in six
ﬁelds for Non-Tg and TgCRND8 NPCs. The percent dead
(ratio of PI-positive/Hoechst-positive cells) was calculated
for each ﬁeld and compared using a Mann–Whitney
U-test using the Prism statistical analysis software.Statistical analysis
Data are expressed as means ± standard deviation
(S.D.) and statistical comparisons were performed with
the two-way analysis of variance (ANOVA) or the Mann–
Whitney U-test. Values that were statistically signiﬁcant
(p< 0.0001, p< 0.01 or p< 0.05) are indicated with an
asterisk. Numbers of animals examined and replicates
are provided in the appropriate ﬁgure legends.RESULTS
The TgCRND8 transgenic mouse line is an aggressive
model of Alzheimer-related amyloid pathology that
results in widespread plaque deposition in the cortex
and hippocampus at 4 months of age. Although APP
expression in the transgenics is high post-natal, the
levels of both Ab40 and Ab42 are only modestly
elevated in the transgenics after birth (30–50 ng/g) as
compared to Non-Tgs until about 8 weeks of age.
However, at 9–10 weeks of age both Ab40 and Ab42
increase dramatically in the TgCRND8 mice (Chishti
et al., 2001). At this stage, Ab42 is elevated more than
10-fold and predominates over the Ab40 species leading
to a signiﬁcantly increased Ab42/40 ratio which results
in a rapid acceleration of the amyloid accumulation and
related neuropathological changes. In the present study,
we investigated the changes in neurogenesis during the
transition from low Ab levels to increased soluble,
possibly oligomeric forms, and the early stages of
plaque formation.Proliferation of hippocampal newborn cells is
increased prior to amyloid deposition
BrdU labeling was used to determine whether cell
proliferation is impaired or promoted in TgCRND8 mice.
In animal injected at 5 weeks (low brain Ab levels) and
the majority of the BrdU-positive newborn cells were seen
in the ﬁrst 2 weeks post-injection. The number of BrdU-
positive cells subsequently decreased by half within
4 weeks after BrdU injection (Fig. 1). Additionally, the
absolute number of BrdU-positive cell population in the
dentate gyrus of TgCRND8 mice was signiﬁcantly
increased as compared to the Non-Tg littermate controls
(Fig. 1). The initial increase in the number of BrdU-
positive cells in TgCRND8 mice at weeks 1–4 after the
BrdU injection (6–9 weeks of age) occurs prior to the
increase in Ab production. The explanation for this
observation is unclear but, may relate to the high levels of
expression of APP and the presence of high
concentrations of soluble neurotrophic APP (sAPPa/b).
This explanation is supported by several prior
observations including observations that: sAPPa is
neurotrophic and promotes survival of cultured neurons
(Mattson et al., 1993; Mucke et al., 1996); there is a
correlation of in vivo sAPPa with improvements of spatial
memory that could be due to enhanced neurogenesis
(Anderson et al., 1998); and secreted APP can promote
proliferation of hippocampal NPCs in culture (Baratchi
et al., 2012). It would be interest as part of a future study
to examine the eﬀects of c-secretase inhibitors and
determine if decreased levels of sAPPa correlated with any
changes in observed increase in the progenitor population.Diﬀerentiation of labeled progenitors in young
TgCRND8 mice
To identify the cell types undergoing diﬀerentiation in
TgCRND8 mice during the period between 5 weeks and
8 weeks of age (i.e. prior to the onset of increased brain
Ab), sections were counterstained with markers for
Fig. 1. Cell proliferation in Non-Tg and TgCRND8 mice. Animals were injected with BrdU at 5 weeks of age and examined at selected time points
over an eight-week period. Immunocytochemistry analysis of BrdU incorporation indicated that the majority of the BrdU-positive cells were found in
the dentate gyrus. The number of BrdU-positive cells was greater in TgCRND8 compared to Non-Tg littermates. Two-way ANOVA revealed
signiﬁcant diﬀerences between TgCRND8 and Non-Tg at each time point. Data are means ± S.D. n= 5 (⁄p< 0.0001).
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markers revealed that BrdU+/NeuN+ cells were the
most predominant class of newly born cells at 1 week
post-injection of BrdU in the 5-week-old TgCRND8 mice
(Fig. 2A). In contrast, newly generated astrocytes
marked by BrdU+/S100b+ (Fig. 2B) or by BrdU+/
GFAP+ (Fig. 2C) were less prevalent.
Careful quantiﬁcation of the BrdU-positive neuronal
and astrocytic revealed the surprising observation that
although there were more BrdU-positive cells overall in
5-week-old TgCRND8 than in Non-Tg mice, there was a
tendency towards a reduction in the number of BrdU+/
NeuN+ or BrdU+/S100b+, and more BrdU+ alone
cells compared to Non-Tg littermates at both one week
and 8 weeks after the BrdU injection (Fig. 3). BecauseFig. 2. Confocal microscopy images of BrdU with neuronal and glial ma
immunostaining conducted in TgCRND8 amyloid mice at 6 weeks of age (1
BrdU (red) and a marker of mature neurons NeuN (green), (B) astrocytic
progenitor marker GFAP (green). Scale bar = 100 lm.of the high variability in cell counts, this trend only
reached statistical signiﬁcance for BrdU+/GFAP+
double-labeled progenitor cells (Fig. 3A). Nevertheless,
these results suggest that even in young TgCRND8
mice the diﬀerentiation to NPCs in dentate gyrus is
impaired even though the total number of proliferating,
BrdU-positive cells was increased.Neural progenitor cell viability and Ab processing
in vitro
To determine why the newborn cells in TgCRND8 brain
had reduced diﬀerentiation into neuronal or glial lines,
we isolated neural progenitors from TgCRND8 mice and
Non-Tg littermates at 14 weeks of age and examinedrkers in the dentate gyrus. Representative images are shown for
week post-injection of BrdU). (A) Brain sections were co-labeled with
marker S100b (green), and (C) astrocytes or Type 1 hippocampal
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Fig. 3. Diﬀerentiation of newborn cells in Non-Tg and TgCRND8 mice. BrdU-labeled cells co-expressing mature neural marker NeuN, mature
astrocytic marker S100b or astrocyte/Type 1 hippocampal progenitor marker GFAP were examined at diﬀerent time points in TgCRND8 mice as
compared to Non-Tg littermates. (A) One week after BrdU injection in 5-week-old mice, the number of BrdU immunoreactive cells co-labeled with
neural/glial markers in the dentate gyrus was counted. (B) Eight weeks after BrdU injection into 5-week-old mice, the number of BrdU-
immunoreactive cells co-labeled with neural/glial markers in the dentate gyrus was counted. Data are means ± S.D. n= 5 (⁄p< 0.05).
Fig. 4. Viability assessments of neurospheres. Cells were isolated from TgCRND8 and non-transgenic littermates at 14 weeks of age and
maintained in culture for a period of 4 days. (A) Propidium iodide and (B) Hoechst 33258 staining of Non-Tg mouse neurospheres with (C) visible
microscopy. (D) Propidium iodide staining of neurospheres isolated from TgCRND8 mice indicated increased levels of cell death. (E) Hoechst
33258 staining of TgCRND8 neuropheres and (F) visible microscopy.
56 S. Kanemoto et al. / Neuroscience 261 (2014) 52–59these progenitor cells for changes in cell viability and Ab
secretion. As a measure of cell death, PI uptake was
assessed in cells grown in culture. At 4 days in culture,
TgCRND8 neural progenitors showed a signiﬁcantlyhigher percentage of PI-positive cells as a ratio of
Hoechst nuclear staining (Fig. 4). Quantiﬁcation of cell
viability indicated that the TgCRND8 neurospheres had
an 15% higher level of cell death based on PI-staining
S. Kanemoto et al. / Neuroscience 261 (2014) 52–59 57as compared to Non-Tg cells (Fig. 5A). By 7 days of
culture, cell death was so extensive in the TgCRND8
neurospheres that cultures were no longer viable and
comparisons with the Non-Tg cells were not possible
(data not shown).
To determine whether the accelerated mortality of the
neural progenitors might arise from the secretion of
neurotoxic Ab42 into the medium, we used a standard
ELISA to assess Ab levels in media from Non-Tg and
TgCRND8 cultures. The media from control culturesA
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58 S. Kanemoto et al. / Neuroscience 261 (2014) 52–59B). Immunoblotting of cell lysates conﬁrmed the high
expression of full-length APP in the TgCRND8 mice as
compared to Non-Tg mice as well as cells stably
expressing the APPSw mutant (Fig. 6C). In addition,
treatment with Compound E resulted in a substantial
increase in the APP C-terminal fragment of NPCs
isolated from the TgCRND8 mice (Fig. 6C). A
detectable increase in the APP-CTF from Non-Tg cells
was also observed which is consistent with the
c-secretase inhibition. Under these conditions, viability
of the TgCRND8 progenitor cells was only modestly
decreased suggesting that decreased Ab secretion may
be only one of the contributing factors in the observed
NPC toxicity (Fig. 6D). However, this may be
complicated by the inherent toxicity of the APP-CTF as
has been shown in several previous instances (Song
et al., 1998; Berger-Sweeney et al., 1999). The
cytotoxic properties of the APP-CTF (or C99) were
recently reported in the triple transgenic mouse model
where elevations of this fragment resulted in extensive
neurodegeneration prior to Ab deposition (Lauritzen
et al., 2012). In this case, pharmacological intervention
with a comparable c-secretase inhibitor (ELN006)
resulted in signiﬁcant cell toxicity in the absence of Ab
secretion similar to that observed for Compound
E-treated NPCs extracted from the TgCRND8 mice.
Therefore inhibition of the c-secretase complex and the
subsequent accumulation of the APP-CTF may
contribute to the observed cell loss and mask the eﬀects
of any Ab cytotoxicity under these conditions. To
determine the extent of amyloid-mediated toxicity, it may
therefore be necessary to target Ab by diﬀerent
approaches such as antibody-mediated removal in cell
culture or prophylactic immunotherapy of TgCRND8
animals to examine if there are any changes in NPC
survival. However, the ﬁndings from our investigation
suggest that high levels of APP and Ab result in a
signiﬁcantly decreased viability of neuroprogenitor cells.CONCLUSION
In the present study, we have shown the increase of
proliferation of newborn cells in the dentate gyrus of the
hippocampus in young TgCRND8 mice compared with
Non-Tg control mice, in contrast, the diﬀerentiation to
NPCs is impaired. Additionally, neurosphere analyses
revealed, cultures isolated from TgCRND8 mice have
low viability and high secreted Ab peptide levels. This
signiﬁcant increase in Ab peptides secreted by
progenitor cells expressing mutant human APP
transgenes may contribute to the cytotoxicity associated
with the TgCRND8 neurospheres, and may be at least
partially why it is not possible to maintain them in
culture for extended periods of time. These ﬁndings
suggest that Ab, possibly as oligomeric species, plays a
key role in the lack of viability of progenitors in vivo and
in vitro. However, contributions from the APP
holoprotein or other APP cleavage fragments such as
amyloid precursor protein intracellular domain (AICD)
cannot presently be fully excluded. Additional
experiments will be needed using chimeric (mutant/wild-type) neurosphere cultures and chimeric transgenic
animals to determine whether the observed defects in
neurogenesis arise from the toxic eﬀects. Ab is
produced by the progenitor cells themselves (i.e. cell
autonomous toxicity). If the toxicity is not cell
autonomous and if wild-type NPCs are also directly
compromised in the presence of high levels of Ab40 and
Ab42, it will have signiﬁcant implications for cell-based
therapy of AD.
The cumulative evidence from the current study is
consistent with a pivotal role for Ab toxicity and possibly
contributions from the APP-CTF in the impairment of
proliferation and survival of NPCs in TgCRND8 mice. A
similar process may be occurring in early-onset forms of
familial AD arising from missense mutant APP,
duplicated APP or Trisomy21 suggesting a potential
double jeopardy of amyloid-induced neuronal loss
coupled with decreased repair abilities and/or decreased
inclusion of new neurons in new memory circuits arising
from APP/Ab-mediated defects in the neurogenesis
pathways. Indeed, impaired neurogenesis in
hippocampal CA3 regions is associated with impaired
spatial memory (Niibori et al., 2012) and both the
hippocampus and spatial memory are aﬀected in AD.FUNDING
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